Search

Social anxiety is a very common disorder and is especially common among individuals with substance abuse or dependence (substance use disorders [SUDs]). Several epidemiologic surveys have estimated the prevalence of [...]

The article discusses accumulated research and clinical focus on comorbid anxiety and substance use disorders, which has provided important insights into the prevalence, development and maintenance patters, clinical impact, and treatment considerations for these intertwined psychiatric problems. Anxiety and substance use disorders are among the most frequent psychiatric problems in the U.S., with lifetime rates of 28.8% and 14.6%, respectively. Critical components of the treatment include psychotherapy and pharmacotherapy.

The article discusses the diagnosis and treatment of substance abuse and social anxiety disorders. According to the findings of epidemiologic surveys, the prevalence of social anxiety disorder in the general population was estimated between 3 to 13 percent. Neurotransmitter dopamine is one potential neurobiological link between the anxiety disorder and substance dependence. It also suggests approaches to treating both disorders.